Harmon Cyrus sold OLMA
July 23, 2026 · Form 4 insider transaction
Harmon Cyrus sold 12,500 shares of Olema Pharmaceuticals, Inc. at $11.58 per share, a transaction worth $144.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
12,500
Price
$11.58
Total value
$144.7K
InsiderHarmon Cyrus
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 23, 2026
Filing dateJuly 27, 2026
Shares owned after715,270
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The weighted average sale price for the transaction reported was $11.579, and the range of prices were between $11.52 and $11.675. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.